Human PIV-2 Recombinant Sendai Virus (rSeV) Elicits Durable Immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV

The human parainfluenza viruses (hPIVs) and respiratory syncytial viruses (RSV) are the leading causes of hospitalizations due to respiratory viral disease in infants and young children, but no vaccines are yet available. Here we describe the use of recombinant Sendai viruses (rSeVs) as candidate va...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jones, Bart, Zhan, Xiaoyan, Mishin, Vasiliy, Slobod, Karen S., Surman, Sherri, Russell, Charles J., Portner, Allen, Hurwitz, Julia L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744503/
https://ncbi.nlm.nih.gov/pubmed/19200447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.01.041
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak